nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—CYP2C9—Omeprazole—Barrett's esophagus	0.193	0.389	CbGbCtD
Bexarotene—CYP3A4—Esomeprazole—Barrett's esophagus	0.19	0.384	CbGbCtD
Bexarotene—CYP3A4—Omeprazole—Barrett's esophagus	0.112	0.226	CbGbCtD
Bexarotene—RXRG—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00814	0.0669	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00765	0.0629	CbGpPWpGaD
Bexarotene—RXRG—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00737	0.0606	CbGpPWpGaD
Bexarotene—RXRB—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00693	0.057	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00643	0.0529	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00605	0.0497	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptors—NR1I2—Barrett's esophagus	0.00399	0.0328	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00363	0.0298	CbGpPWpGaD
Bexarotene—RXRA—Vitamin A and Carotenoid Metabolism—CYP26A1—Barrett's esophagus	0.00361	0.0297	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00341	0.028	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.00315	0.0259	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—CYP26A1—Barrett's esophagus	0.00304	0.025	CbGpPWpGaD
Bexarotene—RXRA—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00277	0.0227	CbGpPWpGaD
Bexarotene—RXRG—Nuclear Receptors—PPARG—Barrett's esophagus	0.00268	0.022	CbGpPWpGaD
Bexarotene—RXRB—Nuclear Receptors—PPARG—Barrett's esophagus	0.00252	0.0207	CbGpPWpGaD
Bexarotene—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.00238	0.0062	CcSEcCtD
Bexarotene—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.00238	0.0062	CcSEcCtD
Bexarotene—Creatinine increased—Omeprazole—Barrett's esophagus	0.00232	0.00604	CcSEcCtD
Bexarotene—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00232	0.00604	CcSEcCtD
Bexarotene—RXRG—Adipogenesis—BMP4—Barrett's esophagus	0.00231	0.019	CbGpPWpGaD
Bexarotene—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.00225	0.00586	CcSEcCtD
Bexarotene—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.00225	0.00586	CcSEcCtD
Bexarotene—RXRA—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.00224	0.0184	CbGpPWpGaD
Bexarotene—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.0022	0.00575	CcSEcCtD
Bexarotene—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.0022	0.00575	CcSEcCtD
Bexarotene—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.0022	0.00575	CcSEcCtD
Bexarotene—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.0022	0.00575	CcSEcCtD
Bexarotene—Eructation—Esomeprazole—Barrett's esophagus	0.00217	0.00565	CcSEcCtD
Bexarotene—Eructation—Omeprazole—Barrett's esophagus	0.00217	0.00565	CcSEcCtD
Bexarotene—Melaena—Omeprazole—Barrett's esophagus	0.00215	0.00562	CcSEcCtD
Bexarotene—Melaena—Esomeprazole—Barrett's esophagus	0.00215	0.00562	CcSEcCtD
Bexarotene—RXRG—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00212	0.0174	CbGpPWpGaD
Bexarotene—Candida infection—Esomeprazole—Barrett's esophagus	0.0021	0.00549	CcSEcCtD
Bexarotene—Candida infection—Omeprazole—Barrett's esophagus	0.0021	0.00549	CcSEcCtD
Bexarotene—Fluid retention—Omeprazole—Barrett's esophagus	0.00209	0.00546	CcSEcCtD
Bexarotene—Fluid retention—Esomeprazole—Barrett's esophagus	0.00209	0.00546	CcSEcCtD
Bexarotene—Dry eye—Esomeprazole—Barrett's esophagus	0.00204	0.00531	CcSEcCtD
Bexarotene—Dry eye—Omeprazole—Barrett's esophagus	0.00204	0.00531	CcSEcCtD
Bexarotene—RXRA—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.00203	0.0167	CbGpPWpGaD
Bexarotene—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.002	0.00523	CcSEcCtD
Bexarotene—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.002	0.00523	CcSEcCtD
Bexarotene—Urine output increased—Omeprazole—Barrett's esophagus	0.00199	0.0052	CcSEcCtD
Bexarotene—Mouth ulceration—Esomeprazole—Barrett's esophagus	0.00199	0.0052	CcSEcCtD
Bexarotene—Neoplasm—Omeprazole—Barrett's esophagus	0.00199	0.0052	CcSEcCtD
Bexarotene—Mouth ulceration—Omeprazole—Barrett's esophagus	0.00199	0.0052	CcSEcCtD
Bexarotene—Urine output increased—Esomeprazole—Barrett's esophagus	0.00199	0.0052	CcSEcCtD
Bexarotene—Neoplasm—Esomeprazole—Barrett's esophagus	0.00199	0.0052	CcSEcCtD
Bexarotene—RXRB—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00199	0.0164	CbGpPWpGaD
Bexarotene—Hypertonia—Esomeprazole—Barrett's esophagus	0.00193	0.00504	CcSEcCtD
Bexarotene—Hypertonia—Omeprazole—Barrett's esophagus	0.00193	0.00504	CcSEcCtD
Bexarotene—Ear pain—Esomeprazole—Barrett's esophagus	0.00188	0.0049	CcSEcCtD
Bexarotene—Ear pain—Omeprazole—Barrett's esophagus	0.00188	0.0049	CcSEcCtD
Bexarotene—Lymphadenopathy—Esomeprazole—Barrett's esophagus	0.00188	0.0049	CcSEcCtD
Bexarotene—Lymphadenopathy—Omeprazole—Barrett's esophagus	0.00188	0.0049	CcSEcCtD
Bexarotene—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.00187	0.0154	CbGpPWpGaD
Bexarotene—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00184	0.0048	CcSEcCtD
Bexarotene—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00184	0.0048	CcSEcCtD
Bexarotene—Polyuria—Esomeprazole—Barrett's esophagus	0.00182	0.00476	CcSEcCtD
Bexarotene—Polyuria—Omeprazole—Barrett's esophagus	0.00182	0.00476	CcSEcCtD
Bexarotene—Gastroenteritis—Omeprazole—Barrett's esophagus	0.00181	0.00471	CcSEcCtD
Bexarotene—Gastroenteritis—Esomeprazole—Barrett's esophagus	0.00181	0.00471	CcSEcCtD
Bexarotene—Vascular purpura—Esomeprazole—Barrett's esophagus	0.00179	0.00467	CcSEcCtD
Bexarotene—Vascular purpura—Omeprazole—Barrett's esophagus	0.00179	0.00467	CcSEcCtD
Bexarotene—Hepatic failure—Omeprazole—Barrett's esophagus	0.00178	0.00465	CcSEcCtD
Bexarotene—Hepatic failure—Esomeprazole—Barrett's esophagus	0.00178	0.00465	CcSEcCtD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—Barrett's esophagus	0.00178	0.0146	CbGpPWpGaD
Bexarotene—Increased appetite—Omeprazole—Barrett's esophagus	0.0017	0.00445	CcSEcCtD
Bexarotene—Increased appetite—Esomeprazole—Barrett's esophagus	0.0017	0.00445	CcSEcCtD
Bexarotene—Renal impairment—Omeprazole—Barrett's esophagus	0.00168	0.00439	CcSEcCtD
Bexarotene—Thirst—Omeprazole—Barrett's esophagus	0.00168	0.00439	CcSEcCtD
Bexarotene—Renal impairment—Esomeprazole—Barrett's esophagus	0.00168	0.00439	CcSEcCtD
Bexarotene—Thirst—Esomeprazole—Barrett's esophagus	0.00168	0.00439	CcSEcCtD
Bexarotene—Purpura—Esomeprazole—Barrett's esophagus	0.00166	0.00433	CcSEcCtD
Bexarotene—Purpura—Omeprazole—Barrett's esophagus	0.00166	0.00433	CcSEcCtD
Bexarotene—Arthritis—Omeprazole—Barrett's esophagus	0.00165	0.0043	CcSEcCtD
Bexarotene—Arthritis—Esomeprazole—Barrett's esophagus	0.00165	0.0043	CcSEcCtD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00163	0.0134	CbGpPWpGaD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00163	0.0134	CbGpPWpGaD
Bexarotene—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00161	0.00419	CcSEcCtD
Bexarotene—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00161	0.00419	CcSEcCtD
Bexarotene—Osteoarthritis—Omeprazole—Barrett's esophagus	0.0016	0.00418	CcSEcCtD
Bexarotene—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.0016	0.00418	CcSEcCtD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGES—Barrett's esophagus	0.00158	0.013	CbGpPWpGaD
Bexarotene—Migraine—Esomeprazole—Barrett's esophagus	0.00158	0.00411	CcSEcCtD
Bexarotene—Migraine—Omeprazole—Barrett's esophagus	0.00158	0.00411	CcSEcCtD
Bexarotene—Face oedema—Esomeprazole—Barrett's esophagus	0.00155	0.00403	CcSEcCtD
Bexarotene—Face oedema—Omeprazole—Barrett's esophagus	0.00155	0.00403	CcSEcCtD
Bexarotene—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.0015	0.00391	CcSEcCtD
Bexarotene—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.0015	0.00391	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—CYP26A1—Barrett's esophagus	0.00149	0.0123	CbGpPWpGaD
Bexarotene—Dry skin—Esomeprazole—Barrett's esophagus	0.00147	0.00383	CcSEcCtD
Bexarotene—Dry skin—Omeprazole—Barrett's esophagus	0.00147	0.00383	CcSEcCtD
Bexarotene—Hypokalaemia—Omeprazole—Barrett's esophagus	0.00146	0.0038	CcSEcCtD
Bexarotene—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.00146	0.0038	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00144	0.00376	CcSEcCtD
Bexarotene—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00144	0.00376	CcSEcCtD
Bexarotene—Muscular weakness—Omeprazole—Barrett's esophagus	0.00141	0.00368	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00141	0.00368	CcSEcCtD
Bexarotene—Muscular weakness—Esomeprazole—Barrett's esophagus	0.00141	0.00368	CcSEcCtD
Bexarotene—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00141	0.00368	CcSEcCtD
Bexarotene—Abdominal distension—Omeprazole—Barrett's esophagus	0.00139	0.00363	CcSEcCtD
Bexarotene—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00139	0.00363	CcSEcCtD
Bexarotene—Dysphagia—Esomeprazole—Barrett's esophagus	0.00138	0.00361	CcSEcCtD
Bexarotene—Influenza—Esomeprazole—Barrett's esophagus	0.00138	0.00361	CcSEcCtD
Bexarotene—Dysphagia—Omeprazole—Barrett's esophagus	0.00138	0.00361	CcSEcCtD
Bexarotene—Influenza—Omeprazole—Barrett's esophagus	0.00138	0.00361	CcSEcCtD
Bexarotene—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00136	0.00354	CcSEcCtD
Bexarotene—Pancreatitis—Omeprazole—Barrett's esophagus	0.00136	0.00354	CcSEcCtD
Bexarotene—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00135	0.00352	CcSEcCtD
Bexarotene—Angina pectoris—Omeprazole—Barrett's esophagus	0.00135	0.00352	CcSEcCtD
Bexarotene—Pancytopenia—Esomeprazole—Barrett's esophagus	0.00131	0.00343	CcSEcCtD
Bexarotene—Pancytopenia—Omeprazole—Barrett's esophagus	0.00131	0.00343	CcSEcCtD
Bexarotene—RXRA—Nuclear Receptors—PPARG—Barrett's esophagus	0.00131	0.0108	CbGpPWpGaD
Bexarotene—Neutropenia—Esomeprazole—Barrett's esophagus	0.00129	0.00338	CcSEcCtD
Bexarotene—Dysuria—Omeprazole—Barrett's esophagus	0.00129	0.00338	CcSEcCtD
Bexarotene—Neutropenia—Omeprazole—Barrett's esophagus	0.00129	0.00338	CcSEcCtD
Bexarotene—Dysuria—Esomeprazole—Barrett's esophagus	0.00129	0.00338	CcSEcCtD
Bexarotene—Pollakiuria—Esomeprazole—Barrett's esophagus	0.00128	0.00333	CcSEcCtD
Bexarotene—Pollakiuria—Omeprazole—Barrett's esophagus	0.00128	0.00333	CcSEcCtD
Bexarotene—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.00127	0.00332	CcSEcCtD
Bexarotene—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.00127	0.00332	CcSEcCtD
Bexarotene—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.00126	0.0033	CcSEcCtD
Bexarotene—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.00126	0.0033	CcSEcCtD
Bexarotene—Weight increased—Esomeprazole—Barrett's esophagus	0.00126	0.00329	CcSEcCtD
Bexarotene—Weight increased—Omeprazole—Barrett's esophagus	0.00126	0.00329	CcSEcCtD
Bexarotene—Weight decreased—Omeprazole—Barrett's esophagus	0.00125	0.00327	CcSEcCtD
Bexarotene—Weight decreased—Esomeprazole—Barrett's esophagus	0.00125	0.00327	CcSEcCtD
Bexarotene—Jaundice—Esomeprazole—Barrett's esophagus	0.0012	0.00314	CcSEcCtD
Bexarotene—Jaundice—Omeprazole—Barrett's esophagus	0.0012	0.00314	CcSEcCtD
Bexarotene—Stomatitis—Omeprazole—Barrett's esophagus	0.0012	0.00314	CcSEcCtD
Bexarotene—Stomatitis—Esomeprazole—Barrett's esophagus	0.0012	0.00314	CcSEcCtD
Bexarotene—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.0012	0.00313	CcSEcCtD
Bexarotene—Conjunctivitis—Omeprazole—Barrett's esophagus	0.0012	0.00313	CcSEcCtD
Bexarotene—Urinary tract infection—Omeprazole—Barrett's esophagus	0.0012	0.00313	CcSEcCtD
Bexarotene—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.0012	0.00313	CcSEcCtD
Bexarotene—RXRA—Biological oxidations—CYP26A1—Barrett's esophagus	0.00119	0.00979	CbGpPWpGaD
Bexarotene—Haematuria—Esomeprazole—Barrett's esophagus	0.00118	0.00307	CcSEcCtD
Bexarotene—Haematuria—Omeprazole—Barrett's esophagus	0.00118	0.00307	CcSEcCtD
Bexarotene—Epistaxis—Esomeprazole—Barrett's esophagus	0.00116	0.00304	CcSEcCtD
Bexarotene—Epistaxis—Omeprazole—Barrett's esophagus	0.00116	0.00304	CcSEcCtD
Bexarotene—Sinusitis—Esomeprazole—Barrett's esophagus	0.00116	0.00302	CcSEcCtD
Bexarotene—Sinusitis—Omeprazole—Barrett's esophagus	0.00116	0.00302	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—BMP4—Barrett's esophagus	0.00113	0.00929	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.00111	0.00913	CbGpPWpGaD
Bexarotene—Rhinitis—Esomeprazole—Barrett's esophagus	0.00111	0.0029	CcSEcCtD
Bexarotene—Rhinitis—Omeprazole—Barrett's esophagus	0.00111	0.0029	CcSEcCtD
Bexarotene—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.0011	0.00287	CcSEcCtD
Bexarotene—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.0011	0.00287	CcSEcCtD
Bexarotene—Pharyngitis—Omeprazole—Barrett's esophagus	0.0011	0.00287	CcSEcCtD
Bexarotene—Pharyngitis—Esomeprazole—Barrett's esophagus	0.0011	0.00287	CcSEcCtD
Bexarotene—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.00109	0.00285	CcSEcCtD
Bexarotene—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.00109	0.00285	CcSEcCtD
Bexarotene—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.00109	0.00285	CcSEcCtD
Bexarotene—Oedema peripheral—Omeprazole—Barrett's esophagus	0.00109	0.00285	CcSEcCtD
Bexarotene—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00109	0.00284	CcSEcCtD
Bexarotene—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00109	0.00284	CcSEcCtD
Bexarotene—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00109	0.00283	CcSEcCtD
Bexarotene—Urethral disorder—Omeprazole—Barrett's esophagus	0.00109	0.00283	CcSEcCtD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.00107	0.00882	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.00107	0.00882	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.00104	0.00859	CbGpPWpGaD
Bexarotene—RXRA—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.00104	0.00852	CbGpPWpGaD
Bexarotene—Eye disorder—Esomeprazole—Barrett's esophagus	0.00103	0.0027	CcSEcCtD
Bexarotene—Eye disorder—Omeprazole—Barrett's esophagus	0.00103	0.0027	CcSEcCtD
Bexarotene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.00103	0.00849	CbGpPWpGaD
Bexarotene—Tinnitus—Esomeprazole—Barrett's esophagus	0.00103	0.00269	CcSEcCtD
Bexarotene—Tinnitus—Omeprazole—Barrett's esophagus	0.00103	0.00269	CcSEcCtD
Bexarotene—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.00102	0.00838	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—PPARG—Barrett's esophagus	0.001	0.00823	CbGpPWpGaD
Bexarotene—Chills—Omeprazole—Barrett's esophagus	0.000993	0.00259	CcSEcCtD
Bexarotene—Chills—Esomeprazole—Barrett's esophagus	0.000993	0.00259	CcSEcCtD
Bexarotene—Alopecia—Esomeprazole—Barrett's esophagus	0.000978	0.00255	CcSEcCtD
Bexarotene—Alopecia—Omeprazole—Barrett's esophagus	0.000978	0.00255	CcSEcCtD
Bexarotene—Malnutrition—Esomeprazole—Barrett's esophagus	0.000964	0.00252	CcSEcCtD
Bexarotene—Malnutrition—Omeprazole—Barrett's esophagus	0.000964	0.00252	CcSEcCtD
Bexarotene—Flatulence—Esomeprazole—Barrett's esophagus	0.00095	0.00248	CcSEcCtD
Bexarotene—Flatulence—Omeprazole—Barrett's esophagus	0.00095	0.00248	CcSEcCtD
Bexarotene—Tension—Omeprazole—Barrett's esophagus	0.000946	0.00247	CcSEcCtD
Bexarotene—Tension—Esomeprazole—Barrett's esophagus	0.000946	0.00247	CcSEcCtD
Bexarotene—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000944	0.00246	CcSEcCtD
Bexarotene—Dysgeusia—Omeprazole—Barrett's esophagus	0.000944	0.00246	CcSEcCtD
Bexarotene—Nervousness—Omeprazole—Barrett's esophagus	0.000936	0.00244	CcSEcCtD
Bexarotene—Nervousness—Esomeprazole—Barrett's esophagus	0.000936	0.00244	CcSEcCtD
Bexarotene—Back pain—Omeprazole—Barrett's esophagus	0.000932	0.00243	CcSEcCtD
Bexarotene—Back pain—Esomeprazole—Barrett's esophagus	0.000932	0.00243	CcSEcCtD
Bexarotene—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000927	0.00242	CcSEcCtD
Bexarotene—Muscle spasms—Omeprazole—Barrett's esophagus	0.000927	0.00242	CcSEcCtD
Bexarotene—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000894	0.00233	CcSEcCtD
Bexarotene—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000894	0.00233	CcSEcCtD
Bexarotene—Anaemia—Esomeprazole—Barrett's esophagus	0.000891	0.00232	CcSEcCtD
Bexarotene—Anaemia—Omeprazole—Barrett's esophagus	0.000891	0.00232	CcSEcCtD
Bexarotene—Agitation—Omeprazole—Barrett's esophagus	0.000886	0.00231	CcSEcCtD
Bexarotene—Agitation—Esomeprazole—Barrett's esophagus	0.000886	0.00231	CcSEcCtD
Bexarotene—Malaise—Esomeprazole—Barrett's esophagus	0.000869	0.00227	CcSEcCtD
Bexarotene—Malaise—Omeprazole—Barrett's esophagus	0.000869	0.00227	CcSEcCtD
Bexarotene—Vertigo—Omeprazole—Barrett's esophagus	0.000866	0.00226	CcSEcCtD
Bexarotene—Vertigo—Esomeprazole—Barrett's esophagus	0.000866	0.00226	CcSEcCtD
Bexarotene—Leukopenia—Omeprazole—Barrett's esophagus	0.000863	0.00225	CcSEcCtD
Bexarotene—Leukopenia—Esomeprazole—Barrett's esophagus	0.000863	0.00225	CcSEcCtD
Bexarotene—Palpitations—Esomeprazole—Barrett's esophagus	0.000852	0.00222	CcSEcCtD
Bexarotene—Palpitations—Omeprazole—Barrett's esophagus	0.000852	0.00222	CcSEcCtD
Bexarotene—Cough—Esomeprazole—Barrett's esophagus	0.000841	0.00219	CcSEcCtD
Bexarotene—Cough—Omeprazole—Barrett's esophagus	0.000841	0.00219	CcSEcCtD
Bexarotene—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000838	0.00688	CbGpPWpGaD
Bexarotene—Hypertension—Esomeprazole—Barrett's esophagus	0.000832	0.00217	CcSEcCtD
Bexarotene—Hypertension—Omeprazole—Barrett's esophagus	0.000832	0.00217	CcSEcCtD
Bexarotene—Arthralgia—Omeprazole—Barrett's esophagus	0.000821	0.00214	CcSEcCtD
Bexarotene—Chest pain—Esomeprazole—Barrett's esophagus	0.000821	0.00214	CcSEcCtD
Bexarotene—Myalgia—Esomeprazole—Barrett's esophagus	0.000821	0.00214	CcSEcCtD
Bexarotene—Chest pain—Omeprazole—Barrett's esophagus	0.000821	0.00214	CcSEcCtD
Bexarotene—Myalgia—Omeprazole—Barrett's esophagus	0.000821	0.00214	CcSEcCtD
Bexarotene—Arthralgia—Esomeprazole—Barrett's esophagus	0.000821	0.00214	CcSEcCtD
Bexarotene—Anxiety—Omeprazole—Barrett's esophagus	0.000818	0.00213	CcSEcCtD
Bexarotene—Anxiety—Esomeprazole—Barrett's esophagus	0.000818	0.00213	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000815	0.00213	CcSEcCtD
Bexarotene—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000815	0.00213	CcSEcCtD
Bexarotene—Discomfort—Esomeprazole—Barrett's esophagus	0.000811	0.00212	CcSEcCtD
Bexarotene—Discomfort—Omeprazole—Barrett's esophagus	0.000811	0.00212	CcSEcCtD
Bexarotene—Dry mouth—Esomeprazole—Barrett's esophagus	0.000803	0.00209	CcSEcCtD
Bexarotene—Dry mouth—Omeprazole—Barrett's esophagus	0.000803	0.00209	CcSEcCtD
Bexarotene—Confusional state—Omeprazole—Barrett's esophagus	0.000793	0.00207	CcSEcCtD
Bexarotene—Confusional state—Esomeprazole—Barrett's esophagus	0.000793	0.00207	CcSEcCtD
Bexarotene—Infection—Omeprazole—Barrett's esophagus	0.000781	0.00204	CcSEcCtD
Bexarotene—Infection—Esomeprazole—Barrett's esophagus	0.000781	0.00204	CcSEcCtD
Bexarotene—Shock—Esomeprazole—Barrett's esophagus	0.000774	0.00202	CcSEcCtD
Bexarotene—Shock—Omeprazole—Barrett's esophagus	0.000774	0.00202	CcSEcCtD
Bexarotene—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000771	0.00201	CcSEcCtD
Bexarotene—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000771	0.00201	CcSEcCtD
Bexarotene—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00077	0.00201	CcSEcCtD
Bexarotene—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00077	0.00201	CcSEcCtD
Bexarotene—Tachycardia—Omeprazole—Barrett's esophagus	0.000768	0.002	CcSEcCtD
Bexarotene—Tachycardia—Esomeprazole—Barrett's esophagus	0.000768	0.002	CcSEcCtD
Bexarotene—Skin disorder—Esomeprazole—Barrett's esophagus	0.000764	0.00199	CcSEcCtD
Bexarotene—Skin disorder—Omeprazole—Barrett's esophagus	0.000764	0.00199	CcSEcCtD
Bexarotene—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00076	0.00198	CcSEcCtD
Bexarotene—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00076	0.00198	CcSEcCtD
Bexarotene—Anorexia—Esomeprazole—Barrett's esophagus	0.00075	0.00196	CcSEcCtD
Bexarotene—Anorexia—Omeprazole—Barrett's esophagus	0.00075	0.00196	CcSEcCtD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—Barrett's esophagus	0.000746	0.00613	CbGpPWpGaD
Bexarotene—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000744	0.00612	CbGpPWpGaD
Bexarotene—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000717	0.00187	CcSEcCtD
Bexarotene—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000717	0.00187	CcSEcCtD
Bexarotene—Insomnia—Omeprazole—Barrett's esophagus	0.000711	0.00186	CcSEcCtD
Bexarotene—Insomnia—Esomeprazole—Barrett's esophagus	0.000711	0.00186	CcSEcCtD
Bexarotene—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000706	0.00184	CcSEcCtD
Bexarotene—Paraesthesia—Omeprazole—Barrett's esophagus	0.000706	0.00184	CcSEcCtD
Bexarotene—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000701	0.00183	CcSEcCtD
Bexarotene—Dyspnoea—Omeprazole—Barrett's esophagus	0.000701	0.00183	CcSEcCtD
Bexarotene—Somnolence—Omeprazole—Barrett's esophagus	0.000699	0.00182	CcSEcCtD
Bexarotene—Somnolence—Esomeprazole—Barrett's esophagus	0.000699	0.00182	CcSEcCtD
Bexarotene—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000692	0.00181	CcSEcCtD
Bexarotene—Dyspepsia—Omeprazole—Barrett's esophagus	0.000692	0.00181	CcSEcCtD
Bexarotene—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000684	0.00178	CcSEcCtD
Bexarotene—Decreased appetite—Omeprazole—Barrett's esophagus	0.000684	0.00178	CcSEcCtD
Bexarotene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000682	0.0056	CbGpPWpGaD
Bexarotene—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000679	0.00177	CcSEcCtD
Bexarotene—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000679	0.00177	CcSEcCtD
Bexarotene—Fatigue—Esomeprazole—Barrett's esophagus	0.000678	0.00177	CcSEcCtD
Bexarotene—Fatigue—Omeprazole—Barrett's esophagus	0.000678	0.00177	CcSEcCtD
Bexarotene—Pain—Esomeprazole—Barrett's esophagus	0.000673	0.00176	CcSEcCtD
Bexarotene—Pain—Omeprazole—Barrett's esophagus	0.000673	0.00176	CcSEcCtD
Bexarotene—Constipation—Esomeprazole—Barrett's esophagus	0.000673	0.00176	CcSEcCtD
Bexarotene—Constipation—Omeprazole—Barrett's esophagus	0.000673	0.00176	CcSEcCtD
Bexarotene—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000673	0.00553	CbGpPWpGaD
Bexarotene—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000648	0.00169	CcSEcCtD
Bexarotene—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000648	0.00169	CcSEcCtD
Bexarotene—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000643	0.00168	CcSEcCtD
Bexarotene—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000643	0.00168	CcSEcCtD
Bexarotene—RXRA—NRF2 pathway—HGF—Barrett's esophagus	0.000624	0.00513	CbGpPWpGaD
Bexarotene—Body temperature increased—Omeprazole—Barrett's esophagus	0.000622	0.00162	CcSEcCtD
Bexarotene—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000622	0.00162	CcSEcCtD
Bexarotene—Abdominal pain—Omeprazole—Barrett's esophagus	0.000622	0.00162	CcSEcCtD
Bexarotene—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000622	0.00162	CcSEcCtD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—RELA—Barrett's esophagus	0.000604	0.00496	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000604	0.00496	CbGpPWpGaD
Bexarotene—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.00058	0.00151	CcSEcCtD
Bexarotene—Hypersensitivity—Omeprazole—Barrett's esophagus	0.00058	0.00151	CcSEcCtD
Bexarotene—Asthenia—Esomeprazole—Barrett's esophagus	0.000564	0.00147	CcSEcCtD
Bexarotene—Asthenia—Omeprazole—Barrett's esophagus	0.000564	0.00147	CcSEcCtD
Bexarotene—RXRA—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000561	0.00461	CbGpPWpGaD
Bexarotene—Pruritus—Omeprazole—Barrett's esophagus	0.000557	0.00145	CcSEcCtD
Bexarotene—Pruritus—Esomeprazole—Barrett's esophagus	0.000557	0.00145	CcSEcCtD
Bexarotene—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000552	0.00454	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000549	0.00451	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000544	0.00447	CbGpPWpGaD
Bexarotene—Diarrhoea—Omeprazole—Barrett's esophagus	0.000538	0.0014	CcSEcCtD
Bexarotene—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000538	0.0014	CcSEcCtD
Bexarotene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000536	0.0044	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—NR1I2—Barrett's esophagus	0.000535	0.0044	CbGpPWpGaD
Bexarotene—Dizziness—Omeprazole—Barrett's esophagus	0.00052	0.00136	CcSEcCtD
Bexarotene—Dizziness—Esomeprazole—Barrett's esophagus	0.00052	0.00136	CcSEcCtD
Bexarotene—RXRA—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	0.000512	0.00421	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—NR1I2—Barrett's esophagus	0.000503	0.00413	CbGpPWpGaD
Bexarotene—Vomiting—Omeprazole—Barrett's esophagus	0.0005	0.00131	CcSEcCtD
Bexarotene—Vomiting—Esomeprazole—Barrett's esophagus	0.0005	0.00131	CcSEcCtD
Bexarotene—Rash—Esomeprazole—Barrett's esophagus	0.000496	0.00129	CcSEcCtD
Bexarotene—Rash—Omeprazole—Barrett's esophagus	0.000496	0.00129	CcSEcCtD
Bexarotene—Dermatitis—Omeprazole—Barrett's esophagus	0.000496	0.00129	CcSEcCtD
Bexarotene—Dermatitis—Esomeprazole—Barrett's esophagus	0.000496	0.00129	CcSEcCtD
Bexarotene—Headache—Esomeprazole—Barrett's esophagus	0.000493	0.00129	CcSEcCtD
Bexarotene—Headache—Omeprazole—Barrett's esophagus	0.000493	0.00129	CcSEcCtD
Bexarotene—RXRA—Adipogenesis—PPARG—Barrett's esophagus	0.000491	0.00403	CbGpPWpGaD
Bexarotene—Nausea—Omeprazole—Barrett's esophagus	0.000467	0.00122	CcSEcCtD
Bexarotene—Nausea—Esomeprazole—Barrett's esophagus	0.000467	0.00122	CcSEcCtD
Bexarotene—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000445	0.00366	CbGpPWpGaD
Bexarotene—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000439	0.00361	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	0.000378	0.00311	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000374	0.00307	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000366	0.003	CbGpPWpGaD
Bexarotene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000353	0.0029	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000344	0.00283	CbGpPWpGaD
Bexarotene—RXRA—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	0.000314	0.00258	CbGpPWpGaD
Bexarotene—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00031	0.00254	CbGpPWpGaD
Bexarotene—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000293	0.00241	CbGpPWpGaD
Bexarotene—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000289	0.00238	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	0.000284	0.00233	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGES—Barrett's esophagus	0.000269	0.00221	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—NR1I2—Barrett's esophagus	0.000262	0.00215	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000225	0.00185	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—CYP26A1—Barrett's esophagus	0.000204	0.00168	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—PPARG—Barrett's esophagus	0.000179	0.00147	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—PPARG—Barrett's esophagus	0.000176	0.00145	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	0.000169	0.00139	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—PPARG—Barrett's esophagus	0.000169	0.00139	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—PPARG—Barrett's esophagus	0.000166	0.00136	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	0.000151	0.00124	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—SLC9A1—Barrett's esophagus	0.000147	0.00121	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—RELA—Barrett's esophagus	0.000137	0.00112	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	0.000118	0.000974	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGES—Barrett's esophagus	0.0001	0.000825	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—PPARG—Barrett's esophagus	8.63e-05	0.000709	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	7.61e-05	0.000625	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PPARG—Barrett's esophagus	6.71e-05	0.000551	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGES—Barrett's esophagus	6.62e-05	0.000544	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	5.62e-05	0.000462	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	5.49e-05	0.000451	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PTGS2—Barrett's esophagus	5.28e-05	0.000434	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	5.02e-05	0.000412	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	4.42e-05	0.000363	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	3.62e-05	0.000297	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PPARG—Barrett's esophagus	2.5e-05	0.000206	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	1.97e-05	0.000162	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PPARG—Barrett's esophagus	1.65e-05	0.000136	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.3e-05	0.000107	CbGpPWpGaD
